Intravascular contrast media and the blood-brain barrier. Testing the new nonionic agent ioxilan.
Intravascular contrast media and the blood-brain barrier. Testing the new nonionic agent ioxilan.
复制标题
血管内造影剂和血脑屏障。
DOI:
10.1097/00004424-198901000-00009
复制
发表时间:
1989
影响因子:
6.7
通讯作者:
Mukherji,M
中科院分区:
文献类型:
--
作者:
Harnish,PP;Krutchen,A;Mukherji,M
The effects of diatrizoate, iohexol, and ioxilan on the blood-brain barrier (BBB) were investigated in normal and hypertensive rats. Anesthetized Wistar rats received 14C-inulin as an indicator for BBB disruption. Diatrizoate, iohexol, or ioxilan (350 and 175 mgl/mL) or normal saline was then injected into the carotid artery (2 mL in 30 seconds). Twenty minutes later, the cardiovascular system was flushed, the brain removed, and each hemisphere was digested. BBB disruption, expressed as counts/minute/mg protein, was compared for each hemisphere in each group by analysis of variance. BBB damage in the diatrizoate-350 group was significantly greater than that in all other groups. No significant BBB damage resulted from iohexol or ioxilan relative to normal saline.